All Lots of Liptruzet in U.S. Recalled Over Packaging Defect (FREE)
By Larry Husten
All lots of the combination cholesterol-lowering drug Liptruzet (ezetimibe and atorvastatin) in the U.S. are being recalled because a packaging defect could …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
More News: Atorvastatin Calcium | Cholesterol | Lipitor | Primary Care | Statin Therapy | Vytorin | Zetia | Zivast